DE69306263D1 - Neue pharmazeutische formulierung enthaltend spiramycine - Google Patents

Neue pharmazeutische formulierung enthaltend spiramycine

Info

Publication number
DE69306263D1
DE69306263D1 DE69306263T DE69306263T DE69306263D1 DE 69306263 D1 DE69306263 D1 DE 69306263D1 DE 69306263 T DE69306263 T DE 69306263T DE 69306263 T DE69306263 T DE 69306263T DE 69306263 D1 DE69306263 D1 DE 69306263D1
Authority
DE
Germany
Prior art keywords
spiramycin
spiramycine
pharmaceutical formulation
formulation containing
new pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69306263T
Other languages
English (en)
Other versions
DE69306263T2 (de
Inventor
Francois-Xavier Piot
Robert Rona
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Publication of DE69306263D1 publication Critical patent/DE69306263D1/de
Application granted granted Critical
Publication of DE69306263T2 publication Critical patent/DE69306263T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DE69306263T 1992-10-05 1993-09-28 Neue pharmazeutische formulierung enthaltend spiramycine Expired - Fee Related DE69306263T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9211747A FR2696346B1 (fr) 1992-10-05 1992-10-05 Nouvelles formulations pharmaceutiques de spiramycine.
PCT/FR1993/000945 WO1994007504A1 (fr) 1992-10-05 1993-09-28 Nouvelles formulations pharmaceutiques de spiramycine
US08/470,319 US5696095A (en) 1992-10-05 1995-06-06 Pharmaceutical formulations of spiramycin

Publications (2)

Publication Number Publication Date
DE69306263D1 true DE69306263D1 (de) 1997-01-09
DE69306263T2 DE69306263T2 (de) 1997-04-17

Family

ID=26229777

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69306263T Expired - Fee Related DE69306263T2 (de) 1992-10-05 1993-09-28 Neue pharmazeutische formulierung enthaltend spiramycine

Country Status (13)

Country Link
US (1) US5696095A (de)
EP (1) EP0662835B1 (de)
JP (1) JPH08501785A (de)
AT (1) ATE145555T1 (de)
CA (1) CA2146251A1 (de)
DE (1) DE69306263T2 (de)
DK (1) DK0662835T3 (de)
ES (1) ES2094566T3 (de)
FI (1) FI951594A (de)
FR (1) FR2696346B1 (de)
GR (1) GR3021788T3 (de)
HU (1) HU214825B (de)
WO (1) WO1994007504A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2793690B1 (fr) * 1999-03-30 2003-01-03 Cll Pharma Formulations pharmaceutiques en macrolides seuls ou associes a d'autres principes actifs et leur utilisation en therapeutique
FR2817751A1 (fr) * 2000-12-07 2002-06-14 Maximun Frederic Yanze Nouvelles compositions pharmaceutiques de sirops et sirops secs contenant de la quinine
EP2201939A1 (de) 2008-12-25 2010-06-30 Zentiva Kimyasal Ürünler Sanayi ve Ticaret A.S. Verfahrung zur Herstellung von beschichtetem Spiramycin und neue Formulierungen damit
CA3036085A1 (en) 2015-09-11 2017-03-16 Andrew Guise An oral particulate composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375468A (en) * 1981-07-13 1983-03-01 Verex Laboratories, Inc. Constant order release aspirin composition and method of treating arthritis
IT1229568B (it) * 1989-04-17 1991-09-04 Giuliani Spa Composizione farmaceutica per uso orale adatta all'impiego nel lavaggio gastro intestinale, in particolare per uso diagnostico, oppure come lassativo catartico.
ES2017559A6 (es) * 1989-10-04 1991-02-16 Rhone Poulenc Farma Sa Procedimiento para la formulacion de la espiramicina.
US5082653A (en) * 1990-10-31 1992-01-21 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and antibiotic
FR2669533B1 (fr) * 1990-11-26 1993-01-08 Rhone Poulenc Rorer Sa Procede de preparation de formulations de spiramycine et formulations orales de spiramycine.

Also Published As

Publication number Publication date
CA2146251A1 (fr) 1994-04-14
GR3021788T3 (en) 1997-02-28
ATE145555T1 (de) 1996-12-15
HU214825B (hu) 1998-06-29
DK0662835T3 (da) 1996-12-16
FI951594A0 (fi) 1995-04-04
JPH08501785A (ja) 1996-02-27
EP0662835B1 (de) 1996-11-27
FI951594A (fi) 1995-04-04
US5696095A (en) 1997-12-09
FR2696346B1 (fr) 1994-11-25
HUT71555A (en) 1995-12-28
EP0662835A1 (de) 1995-07-19
FR2696346A1 (fr) 1994-04-08
HU9500972D0 (en) 1995-06-28
DE69306263T2 (de) 1997-04-17
ES2094566T3 (es) 1997-01-16
WO1994007504A1 (fr) 1994-04-14

Similar Documents

Publication Publication Date Title
ATE205090T1 (de) Eine glucagon enthaltende pharmazeutische zubereitung
DE69011059T3 (de) Heterozyklische Acylaminothiazolderivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE69223914T2 (de) 4-substituierte-2-Deoxy-2,3-Didehydro Alpha-D-Neuraminsäure antivirale Derivate
DK503687A (da) Farmaceutisk praeparat af ibuprofen
NO910213D0 (no) Fremgangsmaate for fremstilling av orale legemiddelformer av pimobendan.
NO954455D0 (no) Farmasöytiske preparater for oral administrasjon av flavonoider
NO894616D0 (no) Fremgangsmaate for fremstilling av anti-aterosklerotisk aktive diarylforbindelser.
ATE151637T1 (de) Heterozyklische verbindungen
SE8704952L (sv) Farmaceutisk komposition
DE69306263D1 (de) Neue pharmazeutische formulierung enthaltend spiramycine
ATE334655T1 (de) Amoxicillin und clavulanat enthaltende pharmazeutische formulierung
JPS5661311A (en) Thial amide or prolonged pharmaceutical preparation comprising its salt
NO913644D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
DK0483320T3 (da) Farmaceutiske sammensætninger med forlænget frigivelse til peroral indgivelse og fremgangsmåde til fremstilling deraf
NO823682L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridazinonimin-derivater.
猪爪信夫 The open-ring analogs of benzodizepine sleep inducers
SE8800026D0 (sv) Anvendning av alkylglycerol for framstellning av lekemedel
DK0560207T3 (da) Præparat til oral anvendelse baseret på ibuprofen
BR9805026A (pt) Compostos contdndo tetrahidrolipstatina
ATE72439T1 (de) 3-propenylcephemderivate, ihre herstellung, zwischenverbindungen, pharmazeutische praeparate und anwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee